Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01583894 · ClinicalTrials.gov registry record
Multiple Areas of Pain (MAP)
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 828
- Enrollment target
NCT01583894: Completed study, sponsored by Boston Scientific Corporation.
NCT01583894 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 828 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01583894 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 828 participants
- Enrollment target
Study Summary
This study will collect pain-related information from chronic pain patients to gain an understanding of the prevalence of multi-site pain, and how it affects health outcomes like function, quality of life, depression, and anxiety.
Primary Outcome
Multiple Site Pain Index (MSPI) was developed by collating multiple pain descriptors into a single index. Pain descriptors used for developing this index were percent body area in pain, number of painful areas, span of painful areas, and Regional Pain Ratings (RPRs) which includes data on pain severity and pain continuity for 47 body regions. MSPI score ranged from 0 to 1; 0 representing no pain and 1 representing extreme continuous pain over entire body, except the head and face regions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 828 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-03 |
What the finished NCT01583894 record still lists
NCT01583894 is an observational study that tracks outcomes without assigning an intervention. The registered 828 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01583894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01583894 about?
NCT01583894 is a clinical study titled "Multiple Areas of Pain (MAP)". This study will collect pain-related information from chronic pain patients to gain an understanding of the prevalence of multi-site pain, and how it affects health outcomes like function, quality of life, depression, and anxiety.
What is the current status of trial NCT01583894?
This trial is currently completed. The enrollment target is 828 participants. The study started on 2012-06. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT01583894?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05124808 · 828 participants · NA
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- NCT03547973 · 827 participants · Phase 2
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia